User login
- /content/hmas-plus-novel-agents-may-improve-outcomes-higher-risk-mds
- /hematologynews/article/228660/myelodysplastic-syndrome/hmas-plus-novel-agents-may-improve-outcomes
- /oncologypractice/article/228660/myelodysplastic-syndrome/hmas-plus-novel-agents-may-improve-outcomes
- /hematology-oncology/article/228660/myelodysplastic-syndrome/hmas-plus-novel-agents-may-improve